about
Major nutritional issues in the management of Parkinson's diseaseMutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson diseaseValvular heart disease and the use of dopamine agonists for Parkinson's diseaseDoes Cognitive Impairment Affect Rehabilitation Outcome in Parkinson's Disease?Genomewide association study for onset age in Parkinson disease.Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.Replication of association between ELAVL4 and Parkinson disease: the GenePD study.The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotectiveThe modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan AfricaParkinson's disease in GTP cyclohydrolase 1 mutation carriers.Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts.Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians.The influence of dopaminergic striatal innervation on upper limb locomotor synergies.Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study.Serum adiponectin levels in advanced-stage Parkinson's disease patients.Differences in muscle strength in parkinsonian patients affected on the right and left side.Clinical correlations with Lewy body pathology in LRRK2-related Parkinson diseaseDopaminergic striatal innervation predicts interlimb transfer of a visuomotor skillIncreased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease.A role for locus coeruleus in Parkinson tremor.Association analysis of PARP1 polymorphisms with Parkinson's disease.SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian populationThe neuromelanin of human substantia nigra: physiological and pathogenic aspects.Mechanical Energy Recovery during Walking in Patients with Parkinson Disease.Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments.Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson's disease.Diet with LPP for renal patients increases daily energy expenditure and improves motor function in parkinsonian patients with motor fluctuationsNeuromelanin Imaging and Dopaminergic Loss in Parkinson's DiseaseThe rationale for improved integration between home care and neurology hospital services in patients with advanced Parkinson's disease.Controlled-protein dietary regimens for Parkinson's disease.Levodopa in Parkinson's disease: from the past to the future.Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: a systematic review.Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.The beneficial role of intensive exercise on Parkinson disease progression.Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.Cognitive status of patients with Parkinson's disease and pathological gambling.Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate.Balance Dysfunction in Parkinson's Disease: The Role of Posturography in Developing a Rehabilitation Program.
P50
Q22252878-CEB9809B-1903-43B9-BD22-FAFADEE55485Q24656075-AE186098-97A3-410A-92F7-FC67D2264EA1Q28281832-41724EDD-67B1-4FE9-85A3-724099C50D23Q28597998-F65A07E0-D467-4FD2-9456-A33963536C79Q29417034-F96F6322-2DBF-49DC-8626-188332AAF1E5Q30438950-D1A2353E-E6CD-4F86-9519-9C26B92DFEC9Q30439050-D7E7FDFE-8BF2-453B-B1CC-DA56769A915DQ30440660-68E10222-FD51-482F-83A5-A547C1B1C008Q30539763-528A42C1-9A63-477B-8BDE-7EE0251044F0Q30586911-9F169580-D2AE-448C-9B99-7C913DB7E21DQ34044060-3F43F6B9-87C1-453C-AF89-E45185C3950DQ34292484-CB47DE0C-D05C-4682-A07B-CF78478F7428Q34411109-38713A83-FA08-4C4F-9F25-6D415871FE19Q34511022-79051959-FC73-4E0C-ADA7-30999B795428Q34718087-8E2144C8-1CCF-4B96-8A91-4D8B68DA157CQ35101405-800F5401-CD54-41A4-AB93-E47897EB7354Q35217388-8FE74F37-1A81-454E-885A-55863AF281DFQ35442728-DFC5826A-7DEA-4985-A18B-AAF06D8A824EQ35539231-B37DD490-36B4-4CFA-95DA-3C4A62746578Q35566218-A27CED67-3269-402C-8ACD-2EEA74108B9BQ35647270-B9DCDBD8-963C-470A-9DAE-E909E76B1CF7Q35662144-174EFC6A-251E-447D-B8D1-A41831317FC1Q35859538-1A4C2EA4-8F76-4184-8BBB-C76CA439979EQ35947281-9DE14FC1-1FC7-4A3B-881F-75EFF40C924EQ36039924-8FFEC96A-3168-4732-A0CD-94885902A322Q36269614-99B71767-0568-4C6D-887B-64F6915426DBQ36457453-9EFDB2DC-69BF-422C-AC1F-1EC7F6195422Q36699948-19A99D02-9C4E-40F8-942F-501F683AD4C3Q37192855-808C2869-0F61-4880-96CB-3FA2BEC04C01Q37453065-FBB20207-2FFC-4ABF-877D-CA9C6CEDD3F8Q37687536-CE5C08F5-673F-4C99-9485-E183DB8C6F7CQ37693934-68D978BA-5203-4C14-A38C-AD1F5A381EFFQ37776460-5BBF0002-B8EE-4AF7-BF13-00B0CBD92F32Q37970653-B6A7A6AB-B552-4F10-8ECC-7BAA47F5B6E0Q38095711-8C1DD27B-D569-40C9-8F89-604893162804Q38374505-5D23F2D9-E6F5-495B-B83A-AB95F3EF9589Q38379198-0B2CFE16-16AF-404D-83A7-218053F07904Q38760546-CD3A0B01-6B69-4285-AE97-DB4BD08188A9Q39117185-B375DBE1-9D7E-4D33-8582-6983D404A8E1Q40389392-EE341B69-761D-498D-B329-0A0CF7A8BA04
P50
name
Gianni Pezzoli
@ast
Gianni Pezzoli
@en
Gianni Pezzoli
@nl
type
label
Gianni Pezzoli
@ast
Gianni Pezzoli
@en
Gianni Pezzoli
@nl
prefLabel
Gianni Pezzoli
@ast
Gianni Pezzoli
@en
Gianni Pezzoli
@nl